HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Focused ultrasound combined with miR-1208-equipped exosomes inhibits malignant progression of glioma.

AbstractBACKGROUND:
Exosomes (Exos) can safely and effectively deliver therapeutic substances to glioma cells; however, their blood-brain barrier (BBB) crossing capacity remains limited. Focused ultrasound (FUS) can transiently, reversibly, and locally open the BBB, while the effects of FUS combined with Exos-miRNA on the treatment of glioma have not been explored to date.
METHODS:
Exos were extracted by differential centrifugation and the efficacy of miR-1208-loaded Exos combined with FUS in the treatment of glioma was detected by CCK-8, colony formation, flow cytometry, transwell and tumour xenografts assays. The METTL3-mediated regulation of IGF2BP2 on mRNA stability of NUP214 was determined by MeRIP-qPCR, half-life and RIP assays.
RESULTS:
We used Exos secreted by mesenchymal stem cells as carriers for the tumour suppressor gene miR-1208, and following FUS irradiation, more Exos carrying miR-1208 were allowed to pass through the BBB, and the uptake of miR-1208 in Exos by glioma cells was promoted, thereby achieving high-efficiency tumour-suppressive effects. Furthermore, the molecular mechanism underlying this effect was elucidated that miR-1208 downregulated the m6A methylation level of NUP214 mRNA by negatively regulating the expression of METTL3, thereby NUP214 expression and TGF-β pathway activity were suppressed.
CONCLUSIONS:
MiR-1208-loaded Exos combined with FUS is expected to become an effective glioma treatment and deserves further clinical evaluation.
AuthorsYing Zhan, Yichen Song, Wei Qiao, Lu Sun, Xin Wang, Bolong Yi, Xinyu Yang, Lian Ji, Peng Su, Wujun Zhao, Zhijun Liu, Weidong Ren
JournalBritish journal of cancer (Br J Cancer) Vol. 129 Issue 7 Pg. 1083-1094 (10 2023) ISSN: 1532-1827 [Electronic] England
PMID37580442 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2023. The Author(s), under exclusive licence to Springer Nature Limited.
Chemical References
  • IGF2BP2 protein, human
  • Methyltransferases
  • METTL3 protein, human
  • MicroRNAs
  • RNA-Binding Proteins
  • MIRN1208 microRNA, human
Topics
  • Humans
  • Blood-Brain Barrier (metabolism)
  • Exosomes (metabolism)
  • Glioma (genetics, therapy, metabolism)
  • Mesenchymal Stem Cells (metabolism)
  • Methyltransferases
  • MicroRNAs (genetics, metabolism)
  • RNA-Binding Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: